Syndicated Quarterly Diabetes Market Share Tracker Europe
Drive key business decisions with brand and product-level information on prescribing behavior for insulin delivery systems (pumps, patches, pens) and glucose monitoring devices (CGM, FGM, BGM) with market sizes and market share by brand with NPS score. Includes drivers and barriers, types of usage and patient preferences, brand attributes ranking, plus country-specific reimbursement landscape and changes, digital health/diabetes apps chapter. In it's fourth year with major Diabetes companies subscribed.
- Quomeda Table of Contents - Quarterly Diabetes Report
- 1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
- 2. RESEARCH METHODOLOGY
- 3. EXECUTIVE SUMMARY
- 4. QUANTITATIVE MARKET POTENTIAL – INDIVIDUAL COUNTRY CHAPTERS: UK, GERMANY, SPAIN, ITALY, FRANCE, NETHERLANDS
- 4.1 Market Overview, Population Demographics
- 4.2 Patients Treated, Type breakdown
- 4.3 Average Number of Prescriptions
- 4.4 Dropout Rates & Reasons
- 4.5 Glucose Monitoring BGM, CGM, FGM
- 4.5.1 Share of Patient Usage, by Technology and Brand
- 4.5.2 Personal vs. Professional CGM
- 4.5.3 Device and Brand usage after Professional CGM
- 4.5.4 Quarterly Prescribing Behaviour
- 4.6 Insulin Delivery Pen, Pump, Patch
- 4.6.1 Share of Patient Usage
- 4.6.2 Quarterly Prescribing Behaviour
- 4.6.3 Insulin Takers Market
- 4.6.4 Sample Practice Patient Split, Insulin Administration
- 4.6.5 Sample Practice Insulin Administration, Glucose Monitoring
- 5. QUANTITATIVE EUROPE COUNTRY COMPARISON
- 9.1 Glucose Monitoring BGM, CGM, FGM
- 9.1.1 Share of Patient Usage
- 9.2 Insulin Delivery Insulin Pe, Durable Pump, Insulin Patch
- 9.2.1 Share of Patient Usage
- 9.3 Prescribing Behavior CGM & FGM
- 9.3.1 Medtronic
- 9.3.2 Abbott
- 9.3.3 Dexcom
- 9.3.4 Other
- 9.4 Prescribing Behavior Durable Pumps & Patch Pumps
- 9.4.1 Roche
- 9.4.2 Medtronic
- 9.4.3 Ypsomed
- 9.4.4 Insulet
- 9.4.5 Animas
- 9.4.6 Other
- 6. QUALITATIVE COUNTRY PROFILE – INDIVIDUAL COUNTRY CHAPTERS: UK, GERMANY, SPAIN, ITALY, FRANCE, NETHERLANDS
- 4.1 Market Changes Glucose Monitoring
- 4.1.1 Reimbursement
- 4.1.2 Patient Preference
- 4.1.3 Guidelines Changes
- 4.1.4 Software Improvements
- 4.2 Device Selection Glucose Monitoring CGM, FGM, BGM
- 4.2.1 Patient Types
- 4.2.2 Patient Selection Drivers
- 4.2.3 Patient Selection Barriers
- 4.3 Brand Selection Glucose Monitoring Drivers & Barriers
- 4.3.1 Brand Choice Drivers
- 4.4.2 Brand Choice Barriers
- 4.4 Brand Selection Glucose Monitoring Performance
- 4.4.1 Brand Choice Drivers
- 4.4.1.1 Dexcom
- 4.4.1.2 Medtronic
- 4.4.1.3 Abbott
- 4.4.1.4 Other
- 4.4.2 Brand Choice Barriers
- 4.4.2.1 Dexcom
- 4.4.2.2 Medtronic
- 4.4.2.3 Abbott
- 4.4.2.4 Other
- 4.5 Reimbursement Status Monitoring Performance
- 4.5.1 FGM
- 4.5.2 CGM
- 4.6 Market Changes Insulin Delivery System
- 4.6.1 Reimbursement
- 4.6.2 Patient Preference
- 4.7 Device Selection Insulin Delivery System Durable Pump, Insulin Patch, Insulin Pen
- 4.2.1 Patient Types
- 4.2.2 Patient Selection Drivers
- 4.2.3 Patient Selection Barriers
- 4.8 Brand Selection Insulin Delivery System Drivers & Barriers
- 4.3.1 Brand Choice Drivers
- 4.3.2 Brand Choice Barriers
- 4.9 Brand Selection Insulin Delivery System Performance
- 4.9.1 Brand Choice Drivers
- 4.9.1.1 Roche
- 4.9.1.2 Medtronic
- 4.9.1.3 Ypsopump
- 4.9.1.4 Omnipod
- 4.9.1.5 Other
- 4.9.2 Brand Choice Barriers
- 4.9.2.1 Roche
- 4.9.2.2 Medtronic
- 4.9.2.3 Ypsopump
- 4.9.2.4 Omnipod
- 4.9.2.5 Other
- 4.10 New Entrants, Threats, Market Inflection Points
- 4.11 Market Trends, Forecasts & Innovative Technologies
- 4.12 Digital Health Influence & Clinical Opinion
- 4.12.1 Patient Conversations and Usage
- 4.12.2 Influence & Decision Drivers
- 4.12.3 Feature & Brand Ranking
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook